Cargando…

Highly sensitive proximity mediated immunoassay reveals HER2 status conversion in the circulating tumor cells of metastatic breast cancer patients

BACKGROUND: The clinical benefits associated with targeted oncology agents are generally limited to subsets of patients. Even with favorable biomarker profiles, many patients do not respond or acquire resistance. Existing technologies are ineffective for treatment monitoring as they provide only sta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Phillip, Liu, Xinjun, Lee, Tani, Liu, Limin, Barham, Robert, Kirkland, Richard, Leesman, Glen, Kuller, Anne, Ybarrondo, Belen, Ng, Shi-Chung, Singh, Sharat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271991/ https://www.ncbi.nlm.nih.gov/pubmed/22172159 http://dx.doi.org/10.1186/1477-5956-9-75

Ejemplares similares

Feedback activation of HER3 attenuates response to EGFR inhibitors in colon cancer cells
por: Bosch-Vilaró, Albert, et al.
Publicado: (2016)

A Novel Proteomics-Based Clinical Diagnostics Technology Identifies Heterogeneity in Activated Signaling Pathways in Gastric Cancers
por: Lee, Jeeyun, et al.
Publicado: (2013)

Signatures of Drug Sensitivity in Nonsmall Cell Lung Cancer
por: Gong, Hua C., et al.
Publicado: (2011)

Activated cMET and IGF1R-Driven PI3K Signaling Predicts Poor Survival in Colorectal Cancers Independent of KRAS Mutational Status
por: Lee, Jeeyun, et al.
Publicado: (2014)

Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients
por: Zhang, Shaohua, et al.
Publicado: (2016)

Liquid Absolute Alcohol Based Sclerotherapy - A Boon in Large Grade 3 Aneurysmal Bone Cyst of Proximal Humerus in a Child
por: Agarwal, Sharat
Publicado: (2020)

HER2-Positive Conversion in a Metastatic Liver Focus in Late Recurrent Breast Cancer
por: Kitahara, Miyuki, et al.
Publicado: (2019)

Trastuzumab in combination with chemotherapy for HER2-positive metastatic gastric cancer patients underwent conversion therapy
por: Zhang, Yanqiang, et al.
Publicado: (2022)

A Conversation with Dawn Pratt: Her Mission to Indigenize STEM
por: Harwitz, Emily
Publicado: (2021)

Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker
por: Liu, Yi, et al.
Publicado: (2013)

A clinically feasible multiplex proteomic immunoassay as a novel functional diagnostic for pancreatic ductal adenocarcinoma
por: Lim, Kian-Huat, et al.
Publicado: (2017)

Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial
por: Jacot, William, et al.
Publicado: (2019)

Primary Megakaryocytes Reveal a Role for Transcription Factor Nf-E2 in Integrin αiibβ3 Signaling
por: Shiraga, Masamichi, et al.
Publicado: (1999)

Frequency of HER2 expression of circulating tumour cells in patients with metastatic or recurrent gastrointestinal cancer
por: Iwatsuki, M, et al.
Publicado: (2013)

Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor()
por: Beije, Nick, et al.
Publicado: (2016)

Nanomaterials-Based Colorimetric Immunoassays
por: Liu, Lin, et al.
Publicado: (2019)

Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer
por: Agelaki, Sofia, et al.
Publicado: (2015)

HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer
por: Nanou, Afroditi, et al.
Publicado: (2020)

Immunoassay of Hormones
por: Bondy, Philip K.
Publicado: (1962)

Generation of a Recombinant scFv against Deoxycholic Acid and Its Conversion to a Quenchbody for One-Step Immunoassay
por: Ueda, Hiroshi, et al.
Publicado: (2023)

HER2-Positive Circulating Tumor Cells in Breast Cancer
por: Ignatiadis, Michail, et al.
Publicado: (2011)

Quantifying HER-2 expression on circulating tumor cells by ACCEPT
por: Zeune, Leonie, et al.
Publicado: (2017)

A Novel Strategy for Detection and Enumeration of Circulating Rare Cell Populations in Metastatic Cancer Patients Using Automated Microfluidic Filtration and Multiplex Immunoassay
por: Magbanua, Mark Jesus M., et al.
Publicado: (2015)

Conversion of a conventional superconductor into a topological superconductor by topological proximity effect
por: Trang, C. X., et al.
Publicado: (2020)

Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer
por: Lee, Kyoungmin, et al.
Publicado: (2023)

HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status
por: Weitsman, Gregory, et al.
Publicado: (2016)

Detection of Circulating VZV-Glycoprotein E-Specific Antibodies by Chemiluminescent Immunoassay (CLIA) for Varicella–Zoster Diagnosis
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2022)

Circulating Antibodies to Skin Bacteria Detected by Serological Lateral Flow Immunoassays Differentially Correlated With Bacterial Abundance
por: Huang, Ryan Yuki, et al.
Publicado: (2021)

Application of Antibody and Immunoassay for Food Safety
por: Lei, Hongtao, et al.
Publicado: (2022)

Flotation Immunoassay: Masking the Signal from Free Reporters in Sandwich Immunoassays
por: Chen, Hui, et al.
Publicado: (2016)

Preliminary association of circulating tumor cells (CTCs) pre- and post-AdHER2 dendritic cell vaccination with overall survival in patients with metastatic HER2+ solid tumors
por: Tomita, Yusuke, et al.
Publicado: (2015)

Recent Advances in the Immunoassays Based on Nanozymes
por: Zhou, Lu, et al.
Publicado: (2022)

A Her2-let-7-β2-AR circuit affects prognosis in patients with Her2-positive breast cancer
por: Liu, Dan, et al.
Publicado: (2015)

Circulating exosomes contain protein biomarkers of metastatic non‐small‐cell lung cancer
por: Wang, Ning, et al.
Publicado: (2018)

Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer
por: Kim, Yun Gyoung, et al.
Publicado: (2017)

Electrochemical Enzyme Immunoassay
por: Halsall, H. Brian, et al.
Publicado: (1988)

The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients
por: Wallwiener, Markus, et al.
Publicado: (2015)

Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer
por: Maillet, Denis, et al.
Publicado: (2021)

Conversion of ER, PR, HER2 and Ki-67 and Prognosis in breast cancer metastases to the brain
por: Jiaxin, Chen, et al.
Publicado: (2022)

Circulating angiopoietin-1 and angiopoietin-2 in critically ill patients: development and clinical application of two new immunoassays
por: Lukasz, Alexander, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_s49co0on4e0t2o47cia32hgon6